Bonjour, new guests from small-town India
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
India too is testing plasma therapy at hospitals in different parts of the country. - Nagara Gopal
The United States Food and Drug Administration (USFDA) has issued an emergency use authorisation (EUA) for investigational convalescent plasma for the treatment of Covid-19 in hospitalised patients as part of the agency’s ongoing efforts to fight the novel coronavirus.
Based on scientific evidence available, the FDA concluded that “this product may be effective in treating Covid-19 and that the known and potential benefits of the product outweigh the known and potential risks of the product.”
The development comes against the political backdrop of the November elections in the US, and the race to have medical treatment options for Covid-19 ahead of D-day. In fact, the last few weeks have seen ambivalent reports in the US on whether plasma therapy did in fact benefit patients.
India too, is testing this therapy at hospitals in different parts of the country.
Meanwhile, the FDA said that its action followed extensive review of the science and data generated over the past several months stemming from efforts to facilitate emergency access to convalescent plasma for patients as clinical trials to definitively demonstrate safety and efficacy remain ongoing.
The EUA authorises the distribution of Covid-19 convalescent plasma in the US and its administration by health care providers, as appropriate, to treat suspected or laboratory-confirmed Covid-19 in hospitalised patients.
In a statement, Stephen M Hahn, FDA Commissioner, said, “We’re encouraged by the early promising data that we’ve seen about convalescent plasma. The data from studies conducted this year shows that plasma from patients who’ve recovered from Covid-19 has the potential to help treat those who are suffering from the effects of getting this terrible virus.”
“At the same time, we will continue to work with researchers to continue randomised clinical trials to study the safety and effectiveness of convalescent plasma in treating patients infected with the novel coronavirus,” he added.
The FDA said it was reasonable to believe that Covid-19 convalescent plasma may be effective in lessening the severity or shortening the length of Covid-19 illness in some hospitalised patients. Possible side-effects of Covid-19 convalescent plasma include allergic reactions, transfusion-associated circulatory overload, and transfusion-associated lung injury, as well as the potential for transfusion-transmitted infections, it said.
The EUA remains in effect until the termination of the declaration that circumstances exist justifying the authorisation of the emergency use of drugs and biologics for prevention and treatment of Covid-19, the agency said, adding that it be revised or revoked if it is determined that the EUA no longer meets the statutory criteria for issuance.
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
Citroen’s first vehicle sports a novel design and European interiors. It is also meant to be as comfortable as ...
The pandemic is only the tip of the iceberg that the country’s cash-poor airlines — both regional and national ...
The government is yet to specify the framework of its recently announced old vehicle scrappage policy
Here is a checklist that equips you to discern the market nuances
Sensex, Nifty 50 have witnessed sharp decline
The fund has consistently outperformed S&P BSE 100 TRI over one, three and five years
Returns are superior to immediate annuity plans, but SCSS can secure better rates for new investors sooner if ...
With the public looking beyond mainstream media for reports from the ground, independent digital platforms are ...
While Supreme Court has cleared the way for women seeking longer tenures and senior roles in the Indian Army, ...
Mughal Gardens in the Capital open to visitors — albeit with Covid-19 protocol — for the annual Udyanotsav
Salty, buttery, cheese coated or with maple syrup and bacon — popcorn is lending its adaptable self to gourmet ...
Its name is the starting point of a brand’s journey and can make a big difference in the success sweepstakes
Sober spirits are the in thing
A peek into where ad spends went last year and where they are headed tomorrow
Can Swiggy Instamart disrupt the ecommerce groceries space, currently ruled by the Amazons and Big Baskets? ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor